Related Experiment Video
Updated: May 24, 2025

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
The Role of HbA1c in the Follow-Up and Control of Diabetes Mellitus
Soliman S Ghanem1, Eman M Abdulkreem2, Muath S Alfurayh3
1Basic Sciences, College of Pharmacy, Rafha, SAU.
Insights
Glycosylated hemoglobin (HbA1c) testing is crucial for diabetes management. Despite high awareness, many diabetic patients in Saudi Arabia have suboptimal follow-up practices, impacting blood sugar control and outcomes.
Area of Science:
- Endocrinology
- Clinical Chemistry
- Public Health
Background:
- Glycosylated hemoglobin (HbA1c) is vital for diagnosing and monitoring diabetes mellitus.
- Comorbidities like kidney disease, anemia, and certain medications can affect HbA1c accuracy.
- Effective diabetes management requires understanding HbA1c's role across diverse patient groups.
Purpose of the Study:
- To evaluate the utility of HbA1c testing in managing diabetes mellitus.
- To assess HbA1c's role in patient follow-up within Saudi Arabia.
- To identify factors influencing HbA1c testing practices and outcomes.
Main Methods:
- Quantitative study utilizing an online electronic questionnaire.
- Questionnaire distributed in English and Arabic via Google Forms.
- Data collected from 412 diabetic patients regarding HbA1c awareness and practice.
Main Results:
- High awareness of HbA1c tests and their importance was observed.
- A significant gap exists between awareness and regular testing practice; most patients tested less frequently than recommended.
- A considerable percentage (35.7%) of patients with HbA1c levels above 10% took no action.
- Average HbA1c levels among participants ranged between 7% and 10%.
Conclusions:
- HbA1c testing remains a cornerstone for diabetes diagnosis and prognosis, improving patient care.
- Regular HbA1c testing every three months is recommended for optimal diabetes control.
- Healthcare providers and patients should not solely rely on post-prandial glucose levels, especially for insulin-dependent diabetics.
Abstract:
Introduction HbA1c is a biomarker that plays an essential role in the diagnosis and follow-up of diabetic patients. The sensitivity and specificity of the biomarker may be affected by common comorbidities seen in individuals with diabetes mellitus, such as kidney affection, cardiac affection, iron deficiency anemia, hemolytic anemia, hemoglobinopathies, and drug consumption. Aim To assess the role of HbA1c in the follow-up and control of Diabetes Mellitus across different patient populations and clinical scenarios. Methodology A quantitative research design to investigate the impact of residence location (inside or outside the Saudi Arabia). Through an electronic questionnaire in English and translated into Arabic, it was published online using Google Forms (Google, Mountain View, California) and was divided into three sections. Results The number of participating patients was 412 diabetic patients; their average age was from 51 to 60 years, and most of them were male. The study found a high level of awareness among diabetics about the HbA1c test, their knowledge of its importance, and their ability to perform the analysis regularly and periodically every year. However, there is a lack of practice, as most participants only performed follow-up every more than a few months, and the value of the last HbA1c test ranged between seven and ten. The percentage of diabetic patients whose cumulative blood sugar was more than ten and who did not take any action after learning of their high percentage (35.7%). Conclusion Diabetes is one of the most common health problems that continue to spread worldwide. HbA1c testing may continue to be implemented as an essential part of the diagnostic and prognostic tool, resulting in better patient care and successful clinical outcomes. Testing for glycosylated hemoglobin levels should be done every three months. Patients and doctors should be cautioned not to rely exclusively on two-hour post-prandial blood glucose results, particularly in the case of insulin-dependent diabetes.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Hypoglycemia and Glucagon

